WIN 2022 Program

INTEGRATING GENOMICS AND TRANSCRIPTOMICS TO RESHAPE PRECISION ONCOLOGY:
A WINNING STRATEGY

Saturday 29 October 2022

WELCOME AND OPENING REMARKS

Image Description

Image Description

8:30

Welcome and Opening Remarks

Richard L. Schilsky

Chairman WIN Consortium, Villejuif, France

Josep Tabernero

Vice-Chairman WIN Consortium, Villejuif, France
Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Image Description

08:50

Opening Keynote Lecture

Re-imagining the (r)evolution in the Precision Oncology paradigm: the future is now

Vivek Subbiah

The University of Texas, MD Anderson Cancer Center, Houston, USA

SESSION 1 - BEYOND DNA TESTING: THE PLACE OF TRANSCRIPTOMICS IN PRECISION ONCOLOGY

Image Description

 

09:20

Keynote Lecture

Expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy

Louis M. Staudt

National Cancer Institute (NCI), Bethesda, USA

Image Description

09:50

Keynote Lecture

Functional genomics to identify cancer vulnerabilities

René Bernards

Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

Image Description

10:20

Accelerating precision oncology using multi-omics and AI

Olivier Elemento

Weill Cornell Medicine, New York, USA

10:50

Coffee break, networking

Image Description

11:15

Modeling gene regulatory processes to understand cancer and identify therapies

John Quackenbush

Harvard T.H. Chan School of Public Health, Boston, USA

Image Description

11:45

SIMS and Digital Display Precision Predictor algorithms

Vladimir Lazar

WIN Consortium, Villejuif, France

Image Description

12:10

Harnessing a synthetic lethality analysis for patient stratification: key role of transcriptomics

Eytan Ruppin

National Institute of Health (NIH), Bethesda, USA

12:35

Panel Discussion

13:00

Lunch, poster viewing and networking

SESSION 2 – INNOVATION IN CLINICAL TRIALS TO ENABLE FUTURE EFFICIENT TREATMENTS

Image Description

14:30

Keynote opening Lecture

Bringing single cell analyses to the clinics

Andrea Califano

Columbia University Medical Center, New York, USA

Image Description

14:55

Keynote lecture

Identifying new uses for approved, targeted drugs: Updates from the ASCO TAPUR study

Richard L. Schilsky

WIN Consortium, Villejuif, France

Image Description

15:20

Genomic and transcriptomic signatures and innovation in CRC
cancers

Josep Tabernero

Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Image Description

15:45

Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: comprehensive tumor genomic and transcriptomic analyses

Jean-François Martini

Pfizer, Inc., San Diego, USA

Image Description

16:10

IO in combination: the SPRING trial tri-therapy approach

Benjamin Solomon

Avera Cancer Institute, Sioux Falls, USA

16:35

Coffee break, networking

17:00

Satellite Symposium - refer to page "Sponsored Session"

18:00

Poster viewing

Welcome Reception

20:00

Symposium Dinner

 

Download the WIN 2022 Program

Download the Program Here

WIN 2022 Symposium
c/o MCI UK Ltd
Ground Floor, Building 1000
Western Road
Portsmouth, Hampshire
PO6 3EZ, UK

Tel: +44 (0) 1730 715223
General enquiries: winsymposium@mci-group.com
Sponsorship enquiries: winsymposium@mci-group.com
Abstract enquiries: winsympabstracts@mci-group.com
Registration enquiries: winsympreghot@mci-group.com

View Our Privacy Policy Here